Phase I/II Study of Carfilzomib in Combination With Bendamustine and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Phase of Trial: Phase I/II
Latest Information Update: 17 Jun 2019
Price : $35 *
At a glance
- Drugs Carfilzomib (Primary) ; Bendamustine; Dexamethasone; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions
- 12 Jun 2019 Status changed from recruiting to completed.
- 30 Jan 2019 Planned End Date changed from 1 Nov 2018 to 30 Jul 2019.
- 30 Jan 2019 Planned primary completion date changed from 1 Nov 2018 to 30 May 2019.